1-20164016-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001367969.2(PLA2G2C):​c.425G>A​(p.Cys142Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

PLA2G2C
NM_001367969.2 missense

Scores

3
6
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.22
Variant links:
Genes affected
PLA2G2C (HGNC:9032): (phospholipase A2 group IIC) Predicted to enable calcium ion binding activity; calcium-dependent phospholipase A2 activity; and phospholipid binding activity. Predicted to be involved in phospholipid metabolic process. Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.932

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLA2G2CNM_001367969.2 linkc.425G>A p.Cys142Tyr missense_variant Exon 5 of 5 ENST00000679259.1 NP_001354898.1
PLA2G2CNM_001316722.3 linkc.416+3G>A splice_region_variant, intron_variant Intron 5 of 5 NP_001303651.1
PLA2G2CXM_047420216.1 linkc.413+3G>A splice_region_variant, intron_variant Intron 2 of 2 XP_047276172.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLA2G2CENST00000679259.1 linkc.425G>A p.Cys142Tyr missense_variant Exon 5 of 5 NM_001367969.2 ENSP00000504292.1 Q5R387
PLA2G2CENST00000247992.5 linkc.428G>A p.Cys143Tyr missense_variant Exon 3 of 3 5 ENSP00000247992.5 J3KMZ3
PLA2G2CENST00000429261.2 linkc.425G>A p.Cys142Tyr missense_variant Exon 4 of 4 5 ENSP00000389335.2 Q5R387
PLA2G2CENST00000495760.2 linkn.164-720G>A intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152216
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000404
AC:
1
AN:
247620
Hom.:
0
AF XY:
0.00000745
AC XY:
1
AN XY:
134302
show subpopulations
Gnomad AFR exome
AF:
0.0000654
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000753
AC:
11
AN:
1461000
Hom.:
0
Cov.:
29
AF XY:
0.00000963
AC XY:
7
AN XY:
726694
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152216
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 31, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.428G>A (p.C143Y) alteration is located in exon 3 (coding exon 3) of the PLA2G2C gene. This alteration results from a G to A substitution at nucleotide position 428, causing the cysteine (C) at amino acid position 143 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.078
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.32
T;.
Eigen
Uncertain
0.25
Eigen_PC
Benign
0.026
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.59
T;T
M_CAP
Benign
0.043
D
MetaRNN
Pathogenic
0.93
D;D
MetaSVM
Benign
-0.64
T
MutationAssessor
Pathogenic
4.2
H;.
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-7.9
D;D
REVEL
Uncertain
0.31
Sift
Uncertain
0.0010
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
D;.
Vest4
0.45
MutPred
0.96
Gain of MoRF binding (P = 0.0683);.;
MVP
0.38
MPC
0.36
ClinPred
1.0
D
GERP RS
4.4
Varity_R
0.87
gMVP
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs757643533; hg19: chr1-20490509; API